cerium has been researched along with Atherogenesis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, A; Cassee, FR; Gosens, I; Lung, S | 1 |
| Boere, AJ; Campbell, A; Cassee, FR; Duffin, R; Gosens, I; Krystek, P; McLean, SG; Miller, MR | 1 |
| Li, L; Li, Q; Shen, X; Tao, Y; Wang, X; Xu, W; Yin, H; Zhong, S | 1 |
| Degirolamo, C; Ishibashi, S; Matsuda, D; Ohshiro, T; Omura, S; Rudel, LL; Sakai, K; Tomoda, H; Yagyu, H | 1 |
| Amamoto, T; Aramaki, H; Fukagawa, K; Fukunishi, Y; Hirayama, A; Imamura, M; Irii, A; Kitajima, S; Kudo, T; Mano, N; Masuyama, T; Noguchi, M; Nomiyama, M; Okamoto, Y; Omiecinski, CJ; Takeda, S; Tatei, S; Tomita, S; Urata, S; Watanabe, K; Yamaguchi, Y | 1 |
| Kim, SH; Lee, ES; Lee, TG; Moon, DW; Shon, HK | 1 |
1 review(s) available for cerium and Atherogenesis
| Article | Year |
|---|---|
An update on lipid oxidation and inflammation in cardiovascular diseases.
Topics: Aortic Valve; Aortic Valve Stenosis; Arachidonic Acids; Atherosclerosis; Calcinosis; Cholesterol Esters; Eicosanoids; Endothelial Cells; Fatty Acids, Unsaturated; Free Radicals; Humans; Inflammation; Lipid Metabolism; Lipid Peroxidation; Lipoprotein(a); Macrophages; Myocardial Infarction; Oxidative Stress; Phospholipids | 2019 |
5 other study(ies) available for cerium and Atherogenesis
| Article | Year |
|---|---|
Brain suppression of AP-1 by inhaled diesel exhaust and reversal by cerium oxide nanoparticles.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blotting, Western; Brain; Cerium; Diet, High-Fat; Electrophoretic Mobility Shift Assay; Gasoline; Inhalation Exposure; Mice, Knockout; Nanoparticles; Pilot Projects; Protective Agents; Transcription Factor AP-1; Vehicle Emissions | 2014 |
The biological effects of subacute inhalation of diesel exhaust following addition of cerium oxide nanoparticles in atherosclerosis-prone mice.
Topics: Animals; Atherosclerosis; Blood Cell Count; Blood Chemical Analysis; Brain; Cerium; Female; Hematocrit; Hemoglobins; Immunohistochemistry; Inhalation Exposure; Lung; Male; Mice; Mice, Knockout; Nanoparticles; Particle Size; Particulate Matter; Random Allocation; Vehicle Emissions | 2012 |
Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Cholesterol Esters; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypercholesterolemia; Intestinal Absorption; Intestines; Lipoproteins, LDL; Lipoproteins, VLDL; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Sesquiterpenes; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Time Factors | 2011 |
Cannabidiol-2',6'-dimethyl ether as an effective protector of 15-lipoxygenase-mediated low-density lipoprotein oxidation in vitro.
Topics: Antioxidants; Arachidonate 15-Lipoxygenase; Atherosclerosis; Cannabidiol; Cholesterol Esters; Cholesterol, LDL; Copper; Humans; Lipoproteins, LDL; Oxidation-Reduction | 2011 |
The regional ratio of cholesteryl palmitate to cholesteryl oleate measured by ToF-SIMS as a key parameter of atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cholesterol Esters; Diet, High-Fat; Disease Progression; Male; Mice; Mice, Knockout; Spectrometry, Mass, Secondary Ion | 2013 |